IR208

IR208 Uses, Dosage, Side Effects, Food Interaction and all others data.

IR208 is a synthetic T-Cell receptor peptidevaccine developed by Immune Response Corporation.It contains three peptides (BV5S2, BV6S5and BV13S1) expressed by T-Cells in over 90% of MSpatients. IR208 is currently undergoing Phase IIstudies in a 200-patient trial.

Table Of contents

• IR208
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	IR208
Generic	IR208
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in multiple sclerosis.

Innovators Monograph

You find simplified version here IR208